Johnson & Johnson

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Johnson & Johnson
CIK #0000200406
Sector Form 13F Holdings Value ($B)
Protagonist Therapeutics Inc 0.3
Nanobiotix Sa 0.2
MeiraGTx Holdings PLC 0.1
Rapport Therapeutics Inc 0.1
CVRX Inc 0.0
Contineum Therapeutics Inc 0.0
Legend Biotech Corp 0.0
Xencor Inc 0.0
Procept Biorobotics Corp 0.0
Fate Therapeutics Inc 0.0
View All
Holdings by Sector ($B)
5.04.03.02.01.00.02019202120242027
EDGAR Form CIK 2011 - 2026
10-K [0000200406]
10-Q [0000200406]
13F-HR [0000200406]
13F-NT [0000200406]
3 [0000200406]
4 [0000200406]
5 [0000200406]
8-K [0000200406]
SC 13G [0000200406]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Johnson & Johnson [2026-05-01]
Johnson & Johnson Rapport Therapeutics Inc [2024-10-18]
Johnson & Johnson Rallybio Corp [2024-07-30]
Johnson & Johnson Contineum Therapeutics Inc [2024-04-10]
Johnson & Johnson Kenvue Inc [2024-01-24]
Johnson & Johnson CVRX Inc [2022-02-07]
State Street Corp Johnson & Johnson [2021-02-12]
Johnson & Johnson Fusion Pharmaceuticals Inc [2020-07-06]
State Street Corp Johnson & Johnson [2020-02-13]
Johnson & Johnson BiomX Inc [2019-11-26]
View All
Form 3/4/5 Subject 2011 - 2026
Johnson & Johnson
Wengel Kathryn E
Woods Eugene A
Hewson Marillyn A
Pinto Daniel E
Reed John C
McClellan Mark B
Morikis John G
Weinberger Mark A
West Nadja
Joly Hubert
Beckerle Mary C
Doudna Jennifer A
Johnson Paula A
Decker Robert J
Schmid Timothy
Forminard Elizabeth
Wolk Joseph J
Mulholland Kristen
Swanson James D
Broadhurst Vanessa
Duato Joaquin
Taubert Jennifer L
CVRx Inc
Johnson & Johnson Development Corp ET AL
Davis D Scott
Mulcahy Anne M
Adamczyk Darius
Contineum Therapeutics Inc
Hait William
Fasolo Peter
Kenvue Inc
McEvoy Ashley
Washington A Eugene
Mongon Thibaut
Gorsky Alex
MeiraGTx Holdings PLC
Mammen Mathai
Ullmann Michael H
Prince Charles
Williams Ronald A
Davis Ian
Sneed Michael E
Stoffels Paulus
Fusion Pharmaceuticals Inc
Perez William D
Kapusta Ronald A
Mesquita Jorge S
Provention Bio Inc
Inspire Medical Systems Inc
Caruso Dominic J
Peterson Sandra E
Achillion Pharmaceuticals Inc
Minerva Neurosciences Inc
Pruden Gary J
Lindquist Susan L
Protagonist Therapeutics Inc
Nevro Corp
Coleman Mary Sue
Aquinox Pharmaceuticals Inc
Mullin Leo F
Cullen James
Cosgrove Stephen J
Aldeyra Therapeutics Inc
Johns Michael M E
Genocea Biosciences Inc
Satcher David
Weldon William C
Deyo Russell C
McCoy Sherilyn S
Universal Biosensors Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Johnson & Johnson JNJ
Deferred Share Units · derivative
2026-03-10 Grant 206.49 $242.14 49,999
Johnson & Johnson JNJ
Deferred Share Units · derivative
2026-03-10 Grant 129.06 $242.14 31,251
Johnson & Johnson JNJ
Deferred Share Units · derivative
2026-03-10 Grant 154.87 $242.14 37,500
Johnson & Johnson JNJ
Common Stock
2026-02-27 Option exercise 4,075 $115.67 471,355
Johnson & Johnson JNJ
Employee Stock Options (Right to Buy) · derivative
2026-02-27 Option exercise 4,075 $0.00
Johnson & Johnson JNJ
Common Stock
2026-02-27 Sell 4,075 $247.87 1,010,070
Johnson & Johnson JNJ
Common Stock
2026-02-20 Sell 1,322 $245.66 324,763
Johnson & Johnson JNJ
Common Stock
2026-02-18 Option exercise 13,625 $115.67 1,576,004
Johnson & Johnson JNJ
Common Stock
2026-02-18 Option exercise 8,998 $129.51 1,165,331
Johnson & Johnson JNJ
Common Stock
2026-02-18 Sell 13,625 $244.20 3,327,225
Johnson & Johnson JNJ
Common Stock
2026-02-18 Sell 8,998 $244.53 2,200,281
Johnson & Johnson JNJ
Employee Stock Options (Right to Buy) · derivative
2026-02-18 Option exercise 8,998 $0.00
Johnson & Johnson JNJ
Employee Stock Options (Right to Buy) · derivative
2026-02-18 Option exercise 13,625 $0.00
Johnson & Johnson JNJ
Common Stock
2026-02-17 Option exercise 12,066 $129.51 1,562,668
Johnson & Johnson JNJ
Common Stock
2026-02-17 Sell 19,241 $242.99 4,675,371
Johnson & Johnson JNJ
Common Stock
2026-02-17 Sell 12,066 $242.87 2,930,469
Johnson & Johnson JNJ
Common Stock
2026-02-17 Sell 29,927 $243.00 7,272,261
Johnson & Johnson JNJ
Employee Stock Options (Right to Buy) · derivative
2026-02-17 Option exercise 33,386 $0.00
Johnson & Johnson JNJ
Common Stock
2026-02-17 Sell 6,197 $243.39 1,508,288
Johnson & Johnson JNJ
Common Stock
2026-02-17 Sell 24,961 $242.68 6,057,535
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com